The suppressive activities of alprenolol against deslanoside-induced cardiotoxicities in guinea pigs.
D000319:Adrenergic beta-Antagonists; D000526:Alprenolol / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D006168:Guinea Pigs; D006329:Heart Conduction System / Q000187:drug effects*; D007799:Lanatosides / Q000037:antagonists & inhibitors*; D011433:Propranolol / Q000008:administration & dosage
D000319:Adrenergic beta-Antagonists; D007799:Lanatosides; D000526:Alprenolol; D011433:Propranolol